Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC

Condition:   Cancer of the Head and Neck Interventions:   Drug: INCAGN01876;   Drug: INCMGA00012;   Biological: DPV-001 Sponsor:   Providence Health & Services Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials